Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price was up 213.7% during mid-day trading on Monday . The stock traded as high as $0.16 and last traded at $0.16. Approximately 100 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 20,342 shares. The stock had previously closed at $0.05.
Cell MedX Stock Up 213.7 %
The stock has a 50-day moving average of $0.20 and a 200 day moving average of $0.09.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
See Also
- Five stocks we like better than Cell MedX
- What Are Trending Stocks? Trending Stocks Explained
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How to Calculate Stock Profit
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
